Amphastar Pharmaceuticals

(NASDAQ) AMPH

Current Price$16.85

Market Cap$743.85M

Since IPO (2014)+69%

5 Year-16%

1 Year-31%

1 Month-22%

Amphastar Pharmaceuticals Financials at a Glance

Market Cap

$743.85M

Revenue (TTM)

$720.53M

Net Income (TTM)

$79.23M

EPS (TTM)

$1.66

P/E Ratio

10.13

Dividend

$0.00

Beta (Volatility)

0.61 (Low)

Dividend

$0.00

Beta (Volatility)

0.61 (Low)

Price

$16.85

Volume

235

Open

$17.27

Price

$16.85

Volume

235

Open

$17.27

Previous Close

$16.87

Daily Range

$16.75 - $17.53

52-Week Range

$16.75 - $31.26

Dividend

$0.00

Beta (Volatility)

0.61 (Low)

Price

$16.85

Volume

235

Open

$17.27

Previous Close

$16.87

Daily Range

$16.75 - $17.53

52-Week Range

$16.75 - $31.26

AMPH News

AMPH: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Amphastar Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Employees

1,976

CEO

Yong Feng Zhang, PhD

Website

www.amphastar.com

Headquarters

Rancho Cucamonga, CA 91730, US

AMPH Financials

Key Financial Metrics (TTM)

Gross Margin

47%

Operating Margin

16%

Net Income Margin

11%

Return on Equity

10%

Return on Capital

Return on Assets

Earnings Yield

9.87%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$743.85M

Shares Outstanding

44.09M

Volume

235

Avg. Volume

596.03K

Financials (TTM)

Gross Profit

$356.06M

Operating Income

$140.40M

EBITDA

$149.10M

Operating Cash Flow

$156.12M

Capital Expenditure

$34.88M

Free Cash Flow

$121.23M

Cash & ST Invst.

$282.81M

Total Debt

$656.00M

Amphastar Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$171.17M

+0.4%

Gross Profit

$70.32M

-17.5%

Gross Margin

41.08%

N/A

Market Cap

$743.85M

N/A

Market Cap/Employee

$366.79K

N/A

Employees

2,028

N/A

Net Income

$6.42M

-74.6%

EBITDA

$13.63M

-74.0%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$391.99M

+5.7%

Accounts Receivable

$147.85M

+1.7%

Inventory

$170.19M

-8.2%

Long Term Debt

$675.00M

+4.7%

Short Term Debt

$11.38M

+42.7%

Return on Assets

4.81%

N/A

Return on Invested Capital

7.87%

N/A

Free Cash Flow

$38.33M

+57.2%

Operating Cash Flow

$47.84M

+36.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

PCRXPacira BioSciences, Inc.

PCRXPacira BioSciences, Inc.$22.64-3.78%

CVACCureVac N.V.

CVACCureVac N.V.$4.66+0.00%

BBNXBeta Bionics, Inc.

BBNXBeta Bionics, Inc.$9.46+2.83%

COLLCollegium Pharmaceutical, Inc.

COLLCollegium Pharmaceutical, Inc.$33.78-3.01%

HROWHarrow Health, Inc.

HROWHarrow Health, Inc.$31.21+1.13%

EMBCEmbecta Corp.

EMBCEmbecta Corp.$3.14+0.00%

AHCOAdaptHealth Corp.

AHCOAdaptHealth Corp.$10.66-0.74%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.06-0.10%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.98+0.05%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$75.34-0.05%

ONDSOndas

ONDSOndas$10.62-0.05%

BMNRBitmine Immersion Technologies

BMNRBitmine Immersion Technologies$19.87-0.10%

FFord Motor Company

FFord Motor Company$13.40-0.07%

TLTiShares Trust - iShares 20+ Year Treasury Bond ETF

TLTiShares Trust - iShares 20+ Year Treasury Bond ETF$83.66-0.01%

Questions About AMPH

What is the current price of Amphastar Pharmaceuticals?

Amphastar Pharmaceuticals is trading at $16.87 per share.

What is the 52-week range for Amphastar Pharmaceuticals?

Over the past 52 weeks, Amphastar Pharmaceuticals has traded between $16.76 and $31.26.

How much debt does Amphastar Pharmaceuticals have?

As of the most recent reporting period, Amphastar Pharmaceuticals reported total debt of $686.38M.

How much cash does Amphastar Pharmaceuticals have on hand?

Amphastar Pharmaceuticals reported $171.17M in cash and cash equivalents in its most recent financial results.

What is Amphastar Pharmaceuticals’s dividend yield?

Amphastar Pharmaceuticals does not currently have a dividend yield.

Amphastar Pharmaceuticals

Amphastar Pharmaceuticals Financials at a Glance

AMPH News

Amphastar Director Sells 16,679 Shares for $441,800

Amphastar: Earnings Miss, Margins Drop

Why Shares of Amphastar Pharmaceuticals Rose Today

Why Amphastar Pharmaceuticals, Inc. is Soaring Today

AMPH: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Amphastar Pharmaceuticals

AMPH Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Amphastar Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About AMPH

What is the current price of Amphastar Pharmaceuticals?

What is the 52-week range for Amphastar Pharmaceuticals?

How much debt does Amphastar Pharmaceuticals have?

How much cash does Amphastar Pharmaceuticals have on hand?

What is Amphastar Pharmaceuticals’s dividend yield?

Premium Investing Services